Modera Wealth Management LLC Has $367,000 Position in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Modera Wealth Management LLC decreased its position in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 34.3% during the fourth quarter, HoldingsChannel reports. The firm owned 4,695 shares of the company’s stock after selling 2,451 shares during the quarter. Modera Wealth Management LLC’s holdings in GE HealthCare Technologies were worth $367,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. LGT Financial Advisors LLC raised its holdings in GE HealthCare Technologies by 1,673.3% in the 3rd quarter. LGT Financial Advisors LLC now owns 266 shares of the company’s stock worth $25,000 after acquiring an additional 251 shares during the period. Capital Performance Advisors LLP acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at about $26,000. Ashton Thomas Securities LLC bought a new position in shares of GE HealthCare Technologies in the third quarter worth about $26,000. Darwin Wealth Management LLC acquired a new position in shares of GE HealthCare Technologies during the 3rd quarter worth about $31,000. Finally, Continuum Advisory LLC boosted its stake in GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after purchasing an additional 168 shares during the period. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Down 2.5 %

NASDAQ GEHC opened at $84.31 on Wednesday. GE HealthCare Technologies Inc. has a 1-year low of $74.51 and a 1-year high of $94.80. The company has a market capitalization of $38.55 billion, a price-to-earnings ratio of 19.47, a PEG ratio of 3.19 and a beta of 1.15. The stock’s 50 day moving average is $86.41 and its two-hundred day moving average is $86.14. The company has a current ratio of 1.04, a quick ratio of 0.83 and a debt-to-equity ratio of 0.88.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings results on Thursday, February 13th. The company reported $1.45 EPS for the quarter, beating the consensus estimate of $1.26 by $0.19. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. The business had revenue of $5.32 billion for the quarter, compared to analyst estimates of $5.33 billion. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts have commented on the company. Wells Fargo & Company lifted their price target on GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Citigroup raised their price objective on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the stock a “buy” rating in a research note on Thursday, February 13th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and upped their target price for the company from $95.00 to $103.00 in a research note on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, eight have assigned a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, GE HealthCare Technologies currently has a consensus rating of “Moderate Buy” and an average target price of $97.67.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.